Therapeutic Targets for Alzheimer's Disease
New Alzheimer's Therapeutics: Pioneering Approaches to Tackle a Growing Concern
Alzheimer's disease (AD) is a complex neurological disorder that significantly impacts the aging population. Molecular biomarkers play pivotal roles in AD's pathological processes, offering potential targets for therapeutic interventions. Sino Biological is at the forefront of Alzheimer's research, offering recombinant Alzheimer's biomarkers for drug discovery and novel therapeutics development.
Featured Products for Alzheimer's Drug Targets
Sino Biological has developed a panel of high-quality recombinant proteins for Alzheimer's drug targets, including APP, Tau, BACE1, ApoE, GLP1R, NGF, BDNF, GSK3B, CASP9, CLU, AGER, DPYSL2, and PNMT with high purity (HPLC-verified) and high bioactivity. These proteins are trusted by users as indicated by citations in top-tier journals. The antibodies against Alzheimer's targets are also available with a variety of applications, such as ELISA, IHC-P, FCM, WB, and IP.
Learn more about Alzheimer's drug targets！
Download Alzheimer's disease target poster to gain more valuable insights.
